RS-17053 2-CYCLOPROPYLMETHOXYPHENOXY)ETHYL]-5-CHLORO-ALPHA, ALPHA-DIMETHYL-1H-INDOLE-3-ETHANAMINE HYDROCHLORIDE), A SELECTIVE ALPHA(1A)-ADRENOCEPTOR ANTAGONIST, DISPLAYS LOW-AFFINITY FOR FUNCTIONAL ALPHA(1)-ADRENOCEPTORS IN HUMAN PROSTATE - IMPLICATIONS FOR ADRENOCEPTOR CLASSIFICATION
Apdw. Ford et al., RS-17053 2-CYCLOPROPYLMETHOXYPHENOXY)ETHYL]-5-CHLORO-ALPHA, ALPHA-DIMETHYL-1H-INDOLE-3-ETHANAMINE HYDROCHLORIDE), A SELECTIVE ALPHA(1A)-ADRENOCEPTOR ANTAGONIST, DISPLAYS LOW-AFFINITY FOR FUNCTIONAL ALPHA(1)-ADRENOCEPTORS IN HUMAN PROSTATE - IMPLICATIONS FOR ADRENOCEPTOR CLASSIFICATION, Molecular pharmacology, 49(2), 1996, pp. 209-215
Norepinephrine (NE) contracts smooth muscle cells within the human low
er urinary tract (LUT) (bladder neck, prostate, and urethra). Receptor
distribution and pharmacological evidence have implicated activation
of alpha(1A)-adrenoceptors. We disclose the pharmacological properties
of the novel, selective alpha(1A)- adrenoceptor antagonist chloro-alp
ha,alpha-dimethyl-1H-indole-3-ethanamine hydrochloride (RS-17053) and
examine critically the pharmacological identity of the alpha(1)-adreno
ceptor mediating contractions to NE in human LUT tissues. In several t
issues from rat and cloned adrenoceptors, RS-17053 displayed high affi
nity for the alpha(1A)-adrenoceptor (pK(i) and pA(2) estimates of 9.1-
9.9) and a 30-100-fold selectivity over the alpha(1B)- and the alpha(1
D)-adrenoceptor subtypes (pK(i) and pA(2) estimates of 7.7-7.8). Howev
er, in isolated smooth muscle preparations from human LUT tissues, RS-
17053 antagonized responses to NE only at high concentrations. Estimat
es of affinity (pA(2)) at alpha(1)-adrenoceptors mediating NE-induced
contractions were 7.5 in prostatic periurethral longitudinal smooth mu
scle (compared with 8.6 for prazosin), 6.9 in anterior fibromuscular s
troma (prazosin, 8.9), and 7.1 in bladder neck (prazosin, 8.5). These
findings indicate that contractile responses to NE in human LUT tissue
s are mediated by a receptor displaying pharmacological properties tha
t are clearly different from those of the defined alpha(1A)-adrenocept
or ii and raise the possibility that multiple forms of the alpha(1A)-a
drenoceptor may exist in human LUT that are discriminated by RS-17053.
In this regard, the affinity estimates obtained with RS-17053 and oth
er alpha(1)-adrenoceptor antagonists in human LUT tissues are identica
l to those described for the putative alpha(1L)-adrenoceptor.